Massachusetts General Hospital
Boston, MA
Filters
Accepting patients
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Learn more- Phase 2
Accepting patients
TRIDENT-1
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
Learn more- Tyrosine Kinase (TK) Inhibitor
- Phase 1/2
- Has results
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials- PI3K Inhibitor
- Tyrosine Kinase (TK) Inhibitor
- Phase 2
Filters
Save & Share
Advanced Filters
Trial Enrollment Status
Phase
Trial Type
Hide Treatments I've Had
This option allows you to hide trials that include all treatments that you have already received.